MedPath

Venn Biosciences Corporation

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages

Completed
Conditions
Colorectal Cancer
First Posted Date
2022-07-06
Last Posted Date
2024-04-23
Lead Sponsor
Venn Biosciences Corporation
Target Recruit Count
3002
Registration Number
NCT05445570
Locations
๐Ÿ‡บ๐Ÿ‡ธ

East View Medical Research, LLD, Mobile, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

Paragon Rx Clinical, Santa Ana, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Encore - Fleming Island Center for Clinical Research, Fleming Island, Florida, United States

and more 8 locations

Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy

Completed
Conditions
Adnexal Mass
Ovarian Cancer
Pelvic Mass
First Posted Date
2019-02-12
Last Posted Date
2024-04-23
Lead Sponsor
Venn Biosciences Corporation
Target Recruit Count
1025
Registration Number
NCT03837327
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Southern California, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Bay Area Gynecology Oncology, San Jose, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Palo Alto Medical Foundation, Sunnyvale, California, United States

and more 23 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.